The chart below correlates cash receipts with sales revenue reported for the Advangen business on a quarterly basis. There is a clear fit between the two sets of figures, with either indicating annualised trend growth for sales in the range 65%-70% pa.
2018 - The Year of the BioTechs, page-676
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable